IL134042A0 - Modified dorsal tissue affecting factor and compositions - Google Patents
Modified dorsal tissue affecting factor and compositionsInfo
- Publication number
- IL134042A0 IL134042A0 IL13404298A IL13404298A IL134042A0 IL 134042 A0 IL134042 A0 IL 134042A0 IL 13404298 A IL13404298 A IL 13404298A IL 13404298 A IL13404298 A IL 13404298A IL 134042 A0 IL134042 A0 IL 134042A0
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- affecting factor
- tissue affecting
- dorsal tissue
- modified
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physical Education & Sports Medicine (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/897,236 US6075007A (en) | 1997-07-17 | 1997-07-17 | Modified noggin polypeptide and compositions |
PCT/US1998/014603 WO1999003996A1 (fr) | 1997-07-17 | 1998-07-17 | Facteur modifie affectant le tissu dorsal et composition a base de ce facteur |
Publications (1)
Publication Number | Publication Date |
---|---|
IL134042A0 true IL134042A0 (en) | 2001-04-30 |
Family
ID=25407592
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13404298A IL134042A0 (en) | 1997-07-17 | 1998-07-17 | Modified dorsal tissue affecting factor and compositions |
IL134042A IL134042A (en) | 1997-07-17 | 2000-01-13 | Modified dorsal tissue affecting factor and compositions |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL134042A IL134042A (en) | 1997-07-17 | 2000-01-13 | Modified dorsal tissue affecting factor and compositions |
Country Status (10)
Country | Link |
---|---|
US (3) | US6075007A (fr) |
EP (1) | EP1003860B1 (fr) |
JP (1) | JP4181300B2 (fr) |
AT (1) | ATE252639T1 (fr) |
AU (1) | AU735851B2 (fr) |
CA (1) | CA2296769C (fr) |
DE (1) | DE69819167T2 (fr) |
HK (1) | HK1026229A1 (fr) |
IL (2) | IL134042A0 (fr) |
WO (1) | WO1999003996A1 (fr) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000011163A1 (fr) | 1998-08-20 | 2000-03-02 | Regeneron Pharmaceuticals, Inc. | Dcr5, proteine de fixation de proteines morphogenetiques osseuses, et ses applications |
US20040009535A1 (en) | 1998-11-27 | 2004-01-15 | Celltech R&D, Inc. | Compositions and methods for increasing bone mineralization |
EP1133558B2 (fr) | 1998-11-27 | 2016-04-13 | UCB Pharma S.A. | Compositions et methodes d'augmentation de la mineralisation de la substance osseuse |
US7306799B2 (en) | 1999-06-08 | 2007-12-11 | Regeneron Pharmaceuticals, Inc. | Use of VEGF inhibitors for treatment of eye disorders |
US7303746B2 (en) | 1999-06-08 | 2007-12-04 | Regeneron Pharmaceuticals, Inc. | Methods of treating eye disorders with modified chimeric polypeptides |
US7070959B1 (en) | 1999-06-08 | 2006-07-04 | Regeneron Pharmaceuticals, Inc. | Modified chimeric polypeptides with improved pharmacokinetic properties |
AU2002243495A1 (en) * | 2001-01-12 | 2002-07-24 | University Of Medicine And Dentistry Of New Jersey | Bone morphogenetic protein-2 in the treatment and diagnosis of cancer |
US20020197648A1 (en) * | 2001-05-02 | 2002-12-26 | Silva Robin M. | High throughput screening methods using magnetic resonance imaging agents |
US20030134790A1 (en) * | 2002-01-11 | 2003-07-17 | University Of Medicine And Dentistry Of New Jersey | Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer |
US7576065B2 (en) * | 2002-02-15 | 2009-08-18 | Cornell Research Foundation, Inc. | Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein |
WO2003087763A2 (fr) | 2002-04-03 | 2003-10-23 | Celltech R & D, Inc. | Association de polymorphismes dans la region du gene sost avec la densite minerale de l'os |
PT1608399E (pt) * | 2003-03-14 | 2012-04-13 | Ucb Mfg Inc | Complexo de esclerostina e noguina ou cordina, e agentes que modulam a formação do referido complexo |
ES2586401T3 (es) | 2003-06-16 | 2016-10-14 | Ucb Pharma S.A. | Anticuerpos específicos para la esclerostina y métodos para aumentar la mineralización ósea |
DK2341147T3 (da) * | 2004-07-09 | 2019-11-11 | Viacyte Inc | Præprimitive stribe- og mesendodermceller |
US8003108B2 (en) | 2005-05-03 | 2011-08-23 | Amgen Inc. | Sclerostin epitopes |
US7592429B2 (en) | 2005-05-03 | 2009-09-22 | Ucb Sa | Sclerostin-binding antibody |
WO2007028212A1 (fr) * | 2005-09-08 | 2007-03-15 | Apollo Life Sciences Limited | Noggine et molécules chimères de celle-ci |
CL2008002775A1 (es) | 2007-09-17 | 2008-11-07 | Amgen Inc | Uso de un agente de unión a esclerostina para inhibir la resorción ósea. |
KR101163171B1 (ko) * | 2009-01-20 | 2012-07-19 | (주)케어젠 | 노긴?유래 펩타이드 및 그의 용도 |
EP2421957B1 (fr) | 2009-04-22 | 2020-11-18 | Viacyte, Inc. | Compositions cellulaires issues de cellules reprogrammées dédifférenciées |
US9109245B2 (en) | 2009-04-22 | 2015-08-18 | Viacyte, Inc. | Cell compositions derived from dedifferentiated reprogrammed cells |
PT3195880T (pt) | 2010-05-14 | 2020-02-21 | Amgen Inc | Formulações de anticorpos antiesclerostina de concentração elevada |
EP2662385A4 (fr) * | 2011-01-07 | 2015-11-11 | Chugai Pharmaceutical Co Ltd | Procédé pour l'amélioration de propriétés physiques d'anticorps |
MX2013010011A (es) | 2011-03-01 | 2014-10-24 | Amgen Inc | Agentes de unión biespecífica. |
KR20140018315A (ko) | 2011-03-25 | 2014-02-12 | 암젠 인크 | 항스클러로스틴 항체 결정 및 이의 제제 |
JO3283B1 (ar) | 2011-04-26 | 2018-09-16 | Sanofi Sa | تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI) |
DK2739311T3 (en) | 2011-08-04 | 2018-04-23 | Amgen Inc | Method of treating bone slit defects |
KR20200056473A (ko) | 2011-12-28 | 2020-05-22 | 암젠 인크 | 항스클레로스틴 항체의 이용을 통한 치조골 소실의 치료 방법 |
EP2869844B2 (fr) | 2012-07-05 | 2023-06-21 | UCB Pharma S.A. | Traitement de maladies osseuses |
UY35148A (es) | 2012-11-21 | 2014-05-30 | Amgen Inc | Immunoglobulinas heterodiméricas |
US8859286B2 (en) | 2013-03-14 | 2014-10-14 | Viacyte, Inc. | In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells |
US9914769B2 (en) | 2014-07-15 | 2018-03-13 | Kymab Limited | Precision medicine for cholesterol treatment |
GB201403775D0 (en) | 2014-03-04 | 2014-04-16 | Kymab Ltd | Antibodies, uses & methods |
ES2732925T3 (es) | 2014-07-18 | 2019-11-26 | Sanofi Sa | Método para predecir el resultado de un tratamiento con aflibercept de un paciente que se sospecha que padece un cáncer |
MA41142A (fr) | 2014-12-12 | 2017-10-17 | Amgen Inc | Anticorps anti-sclérostine et utilisation de ceux-ci pour traiter des affections osseuses en tant qu'élements du protocole de traitement |
GB201604124D0 (en) | 2016-03-10 | 2016-04-27 | Ucb Biopharma Sprl | Pharmaceutical formulation |
US11779604B2 (en) | 2016-11-03 | 2023-10-10 | Kymab Limited | Antibodies, combinations comprising antibodies, biomarkers, uses and methods |
AU2019243595A1 (en) | 2018-03-30 | 2020-09-17 | Amgen Inc. | C-terminal antibody variants |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5256568A (en) | 1990-02-12 | 1993-10-26 | Regeneron Phamaceuticals, Inc. | Vectors and transformed most cells for recombinant protein production with reduced expression of selectable markers |
DE69121208T2 (de) | 1990-09-25 | 1997-01-23 | Genentech Inc | Neuer neurotropischer faktor |
IL134656A (en) * | 1992-09-03 | 2006-12-10 | Univ California | Antibodies that bind the polypeptide nogin and hybridoma capable of producing these antibodies |
WO1994005800A1 (fr) * | 1992-09-03 | 1994-03-17 | The Regents Of The University Of California | Facteur influant sur le tissu dorsal et compositions |
-
1997
- 1997-07-17 US US08/897,236 patent/US6075007A/en not_active Expired - Fee Related
-
1998
- 1998-07-17 AT AT98936850T patent/ATE252639T1/de not_active IP Right Cessation
- 1998-07-17 DE DE69819167T patent/DE69819167T2/de not_active Expired - Lifetime
- 1998-07-17 EP EP98936850A patent/EP1003860B1/fr not_active Expired - Lifetime
- 1998-07-17 AU AU85708/98A patent/AU735851B2/en not_active Ceased
- 1998-07-17 CA CA002296769A patent/CA2296769C/fr not_active Expired - Fee Related
- 1998-07-17 IL IL13404298A patent/IL134042A0/xx active IP Right Grant
- 1998-07-17 WO PCT/US1998/014603 patent/WO1999003996A1/fr active IP Right Grant
- 1998-07-17 JP JP2000503202A patent/JP4181300B2/ja not_active Expired - Fee Related
-
2000
- 2000-01-13 IL IL134042A patent/IL134042A/en not_active IP Right Cessation
- 2000-02-08 US US09/500,253 patent/US6500640B1/en not_active Expired - Fee Related
- 2000-08-24 HK HK00105325A patent/HK1026229A1/xx not_active IP Right Cessation
-
2002
- 2002-12-19 US US10/323,268 patent/US20030129703A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ATE252639T1 (de) | 2003-11-15 |
EP1003860B1 (fr) | 2003-10-22 |
HK1026229A1 (en) | 2000-12-08 |
EP1003860A1 (fr) | 2000-05-31 |
JP2001510044A (ja) | 2001-07-31 |
AU8570898A (en) | 1999-02-10 |
CA2296769C (fr) | 2008-01-15 |
US6500640B1 (en) | 2002-12-31 |
WO1999003996A1 (fr) | 1999-01-28 |
DE69819167T2 (de) | 2004-07-22 |
US6075007A (en) | 2000-06-13 |
DE69819167D1 (de) | 2003-11-27 |
CA2296769A1 (fr) | 1999-01-28 |
US20030129703A1 (en) | 2003-07-10 |
IL134042A (en) | 2006-12-10 |
JP4181300B2 (ja) | 2008-11-12 |
AU735851B2 (en) | 2001-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1026229A1 (en) | Modified dorsal tissue affecting factor and compositions | |
ZA983148B (en) | Modified TNFÓ, DNA encoding such modified TNFÓ and vacines comprising said TNFÓ and DNA. | |
HK1022701A1 (en) | Exendin analogues, processes for their preparationand medicaments containing them exendin. | |
HK1047887A1 (en) | Use of thiazolidin- or pyrrolidin-derivatives of aminoacids as antihyperglycemic agents. | |
EP1019028A4 (fr) | PROTEINE DE $i(CHLAMYDIA), SEQUENCE GENIQUE, ET UTILISATIONS CORRESPONDANTES | |
ZA975211B (en) | Compositions and methods for administering borrelia DNA. | |
BG101132A (en) | Pyridoanilated thienyl and furanyl oxazolidinons | |
GR3024597T3 (en) | 7-deazapurine modified oligonucleotides | |
IL125124A0 (en) | Dimeric forms of the protein fapalpha and uses thereof | |
WO1994005791A3 (fr) | Facteur influant sur la croissance du tissu dorsal et compositions | |
AU1565300A (en) | Anti-germinating method for tubers and bulbs using eugenol and/or isoeugenol | |
EP1123414A4 (fr) | Modulation antisens de l'expression de l'integrine alpha 4 | |
DK1071767T3 (da) | Gen, der koder for heliomicin, og anvendelse heraf | |
ZA971272B (en) | Gene expression. | |
HUP0104825A3 (en) | Genes and proteins, and their use | |
HK1048318A1 (en) | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors. | |
ZA982023B (en) | Personal Gaming System. | |
EP1012297A4 (fr) | Genes codant la polyphenoloxydase, extraits de la banane, du tabac et de l'ananas | |
PE20399A1 (es) | Muteina ob | |
HK1039339A1 (en) | Outer surface proteins, their genes, and their use. | |
EP0970192A4 (fr) | ACIDE NUCLEIQUE CODANT UNE PROTEINE ALGU $i(M. TUBERCULOSIS) | |
IT242987Y1 (it) | Guarnitura per mobili. | |
EP1135476A4 (fr) | Compositions biologiques, leurs constituants et leurs applications | |
DE69930370D1 (de) | Testisspezifische, menschliche proteinase, svph1-8 | |
AU6723898A (en) | Composition for treating tanned leather, and its preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
FF | Patent granted | ||
KB | Patent renewed |